Cargando…

Adherence to nine-month isoniazid for latent tuberculosis infection in healthcare workers: a prospective study in a tertiary hospital

Poor adherence to medication can lead to treatment failure in healthcare workers (HWCs) with latent tuberculosis infection (LTBI) who are at high risk of developing active tuberculosis. However, the factors associated with non-completion of nine-month LTBI treatment with isoniazid (9 H) have not bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Sung Jun, Lee, Hyun, Koo, Gun Woo, Min, Ji-Hee, Yeo, Yoomi, Park, Dong Won, Park, Tai Sun, Moon, Ji-Yong, Kim, Sang-Heon, Kim, Tae Hyung, Sohn, Jang Won, Yoon, Ho Joo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160120/ https://www.ncbi.nlm.nih.gov/pubmed/32296096 http://dx.doi.org/10.1038/s41598-020-63156-8

Ejemplares similares

Factors associated with non-initiation of latent tuberculosis treatment among healthcare workers with a positive interferon-gamma releasing assay
por: Lee, Hyun, et al.
Publicado: (2019)

Isoniazid Prophylaxis for Latent Tuberculosis Infections in Liver Transplant Recipients in a Tuberculosis-Endemic Area
por: Moon, Hyung Hwan, et al.
Publicado: (2017)

Short-Acting Beta2-Agonist Use in Asthma in Korea: A 10-Year Population-Based Study
por: Lee, Hyun, et al.
Publicado: (2021)

Additive Effect of Obesity and Dyslipidemia on Wheezing in Korean Adults: A Nationwide Representative Survey Study
por: Kim, Youlim, et al.
Publicado: (2021)

The Usefulness of FEF(25–75) in Predicting Airway Hyperresponsiveness to Mannitol
por: Kim, Youlim, et al.
Publicado: (2021)

Additive effects of coexisting respiratory comorbidities on overall or respiratory mortality in patients with asthma: a national cohort study
por: Yeo, Yoomi, et al.
Publicado: (2022)

TNF inhibitors increase the risk of nontuberculous mycobacteria in patients with seropositive rheumatoid arthritis in a mycobacterium tuberculosis endemic area
por: Park, Dong Won, et al.
Publicado: (2022)

Risk Factors for Grade 3 to Grade 4 Adverse Reactions to the ChAdOx1 nCoV-19 Vaccine (AZD1222) Against SARS-CoV-2
por: Lee, Sang Won, et al.
Publicado: (2021)

Anti-SARS-CoV-2 Spike Protein RBD Antibody Levels After Receiving a Second Dose of ChAdOx1 nCov-19 (AZD1222) Vaccine in Healthcare Workers: Lack of Association With Age, Sex, Obesity, and Adverse Reactions
por: Lee, Sang Won, et al.
Publicado: (2021)

Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine
por: McClintock, Adelaide H., et al.
Publicado: (2017)

Impact of bronchiectasis on susceptibility to and severity of COVID-19: a nationwide cohort study
por: Choi, Hayoung, et al.
Publicado: (2021)

Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
por: Lai, Wendy A., et al.
Publicado: (2022)

Cost effectiveness of three months of rifapentine and isoniazid for latent tuberculosis in Syrian refugees
por: Ilaiwy, Ghassan, et al.
Publicado: (2021)

Risk of Coronavirus Disease 2019 Occurrence, Severe Presentation, and Mortality in Patients with Lung Cancer
por: Yang, Bumhee, et al.
Publicado: (2021)

Timing of treatment interruption among latently infected tuberculosis cases treated with a nine-month course of daily isoniazid: findings from a time to event analysis
por: Séraphin, Marie Nancy, et al.
Publicado: (2019)

Increased mortality in patients with non cystic fibrosis bronchiectasis with respiratory comorbidities
por: Choi, Hayoung, et al.
Publicado: (2021)

3-month daily rifampicin and isoniazid compared to 6- or 9-month isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review
por: Assefa, Yibeltal, et al.
Publicado: (2018)

Burden of male hardcore smokers and its characteristics among those eligible for lung cancer screening
por: Park, Dong Won, et al.
Publicado: (2020)

Treatment of isoniazid-resistant pulmonary tuberculosis
por: Kim, Yee Hyung, et al.
Publicado: (2008)

Risk Factors of Incident Lung Cancer in Patients with Non-Cystic Fibrosis Bronchiectasis: A Korean Population-Based Study
por: Kim, Youlim, et al.
Publicado: (2022)

A Case of Acute Liver Failure in a Patient on Isoniazid Prophylaxis for Latent Tuberculosis
por: Philipose, Jobin, et al.
Publicado: (2022)

Association between 9-month isoniazid prophylaxis of latent tuberculosis and severe hepatitis in patients treated with TNF inhibitors
por: Lai, Edward Chia-Cheng, et al.
Publicado: (2021)

New-onset asthma following COVID-19 in adults
por: Lee, Hyun, et al.
Publicado: (2023)

Predicting Factors of Severe COVID-19 in Patients With Asthma: A Korean National Cohort Study
por: Lee, Hyun, et al.
Publicado: (2021)

The utility of histological subtype for predicting survival of lung cancer patients with rheumatoid arthritis
por: Park, Dong Won, et al.
Publicado: (2020)

Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapy
por: Sung, Yoon-Kyoung, et al.
Publicado: (2018)

Association between exercise and risk of cardiovascular diseases in patients with non-cystic fibrosis bronchiectasis
por: Choi, Hayoung, et al.
Publicado: (2022)

Acquired Resistance to Isoniazid During Isoniazid Monotherapy in a Subject with Latent Infection Following Household Rifampicin-Resistant Tuberculosis Contact: A Case Report
por: Li, Tsung-Lun, et al.
Publicado: (2021)

Pulmonary Foreign Body Granulomatosis in Dental Technician
por: Chung, Sung Jun, et al.
Publicado: (2015)

Interstitial lung disease increases susceptibility to and severity of COVID-19
por: Lee, Hyun, et al.
Publicado: (2021)

Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis
por: Gerona, Roy, et al.
Publicado: (2016)

Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania
por: Shayo, Grace A., et al.
Publicado: (2015)

Development of Pseudomembranous Colitis Four Months after Initiation of Rifampicin
por: Choi, Jeong Moon, et al.
Publicado: (2011)

Fatal Clinical Course of Probable Invasive Pulmonary Aspergillosis with Influenza B Infection in an Immunocompetent Patient
por: Park, Dong Won, et al.
Publicado: (2014)

Effect of isoniazid on antigen-specific interferon-γ secretion in latent tuberculosis
por: Torres, Martha, et al.
Publicado: (2015)

1694 Risk factors and outcomes of isoniazid hepatotoxicity in children with latent tuberculosis
por: Devrim, Ilker, et al.
Publicado: (2014)

Completion Rate and Side-Effect Profile of Three-Month Isoniazid and Rifapentine Treatment for Latent Tuberculosis Infection in an Urban County Jail
por: Juarez-Reyes, Maria, et al.
Publicado: (2016)

Using Video Technology to Increase Treatment Completion for Patients With Latent Tuberculosis Infection on 3-Month Isoniazid and Rifapentine: An Implementation Study
por: Lam, Chee Kin, et al.
Publicado: (2018)

Publisher Correction: Association between 9-month isoniazid prophylaxis of latent tuberculosis and severe hepatitis in patients treated with TNF inhibitors
por: Lai, Edward Chia‑Cheng, et al.
Publicado: (2021)

Treatment Outcomes of Infectious and Non-infectious Acute Exacerbation of Myositis-Related Interstitial Lung Disease
por: Lee, Hyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j8n1onrb9jggfs7gb8t9lt2g9e